【正文】
探析[J].中國(guó)藥事,(11).[10] 夏旭東.我國(guó)第三方醫(yī)藥物流存在問(wèn)題及發(fā)展對(duì)策[J].中國(guó)藥事,2009,23(2).[11] 陳潔.醫(yī)藥經(jīng)營(yíng)企業(yè)在第三方物流下的質(zhì)量管理探討[J].醫(yī)藥論壇,2011,32(6).[12] Roberta P, Pier P,Daniela P. Supply Chain Coordination and IT : The Role of Third Party Logistics Providers[J]. Management of Hie Interconnected World, 2010(6 )[13] Dieter A, Eijen L,Jan T. Udding,Structural Properties of ThirdParty Logistics Networks [J]. Dynamics in Logistics,2011 (1)[14] Harlanda C Walkera strategic case for eadoption in healthcare supply chains[A].In:Zheng J,Bakker E,Knight L.39。Gilhespy H Journal of Information Management[M]:Elsevier,2006(2) [4] Hokey Min, Seong Jong Joo, Benchmarking the operational efficiency of third party logistics providers using data envelopment analysis [J] .Supply Chain Management: An International Journal, 2006,11(3)[5] Parraga, Procedure in the Event of Cold Chain Failure[J].Farmacia Hospitalaria (English Edition),2011,35(4) [6]Selcuk Percin,Evaluation of thirdparty logistics (3PL) providers by using a twophase AHP and TOPS ISmethodology [J] .Benchmarking: A